Form 4: Fortive Corp Director Sharmistha Dubey Reports Stock and Option Grants

Director Sharmistha Dubey reports the acquisition of Fortive Corp stock and options through restricted stock units (RSUs) and a director stock option grant.

Summary

• On June 3, 2024, Sharmistha Dubey, a director of Fortive Corp, reported transactions involving the company's stock and derivative securities.
• Dubey acquired 1,970 shares of common stock through restricted stock units (Annual Grant RSUs) granted by the issuer.
• Additionally, Dubey acquired 1,645 shares of common stock through restricted stock units (Deferral RSUs) based on a 20-day average price of $76.14, pursuant to a deferral election of $125,000 in annual retainer.
• Dubey also acquired a director stock option (right to buy) for 1,990 shares at an exercise price of $72.95, exercisable from June 3, 2024, and expiring on June 3, 2034.
• Following these transactions, Dubey beneficially owns 16,983 shares of common stock and 1,990 director stock options.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard compensation practices and alignment of director interests with shareholders. The director's decision to defer cash compensation into stock is a positive signal.

Positives

• The grant of restricted stock units and stock options to a director aligns their interests with those of the shareholders.
• The deferral of cash compensation into stock demonstrates the director's confidence in the company's future performance.

Future Outlook

The Annual Grant RSUs and Deferral RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2025 annual meeting of the stockholders. The underlying shares for the Annual Grant RSUs will be delivered upon vesting, while the shares for the Deferral RSUs will be issued upon the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. These transactions are part of standard compensation practices for directors and executives.

Comparison to Industry Standards

• Equity grants to directors are a common practice among publicly traded companies to align their interests with shareholders.
• Companies like Danaher (DHR) and Roper Technologies (ROP), which operate in similar industries, also utilize stock options and restricted stock units as part of their director compensation packages.
• The vesting schedules and terms of these grants are generally in line with industry standards, typically vesting over one to three years.

Stakeholder Impact

• The equity grants align the director's interests with those of the shareholders, potentially leading to better corporate governance and decision-making.
• The director's decision to defer cash compensation into stock demonstrates confidence in the company's future performance, which can positively influence investor sentiment.

Key Dates